TABLE 1.
Analysis |
|||||||||
---|---|---|---|---|---|---|---|---|---|
Characteristic | Patients With Schizophrenia (N=20) | Patients With Affective Psychosis (N=20) | Healthy Comparison Subjects (N=23) | Statistic | df | p | |||
Mean | SD | Mean | SD | Mean | SD | F | |||
Agea (years) | 25.3 | 7.4 | 22.5 | 5.2 | 25.1 | 4.3 | 1.767 | 2, 60 | 0.180 |
Handednessb | 0.81 | 0.16 | 0.74 | 0.16 | 0.79 | 0.17 | 0.994 | 2, 60 | 0.376 |
Socioeconomic statusc | 3.5 | 1.4 | 2.8 | 1.3 | 2.4 | 1.0 | 4.019 | 2, 60 | 0.023 |
Parents’ socioeconomic statusc | 1.8 | 0.6 | 1.5 | 0.8 | 1.4 | 0.6 | 2.368 | 2, 60 | 0.102 |
Mini-Mental State Examination | 28.0 | 2.7 | 29.1 | 1.3 | 29.1 | 1.2 | 2.310 | 2, 60 | 0.108 |
WAIS-R information subscale score | 11.6 | 3.3 | 13.2 | 2.8 | 13.1 | 2.4 | 1.947 | 2, 60 | 0.152 |
WAIS-R digit span subscale score | 10.4 | 3.2 | 10.6 | 2.7 | 11.3 | 3.2 | 0.515 | 2, 60 | 0.600 |
t | |||||||||
Brief Psychiatric Rating Scale score | 37.3 | 12.3 | 31.1 | 8.0 | 1.884 | 39 | 0.067 | ||
Global Assessment Scale score | 36.4 | 7.8 | 41.8 | 11.3 | −1.759 | 39 | 0.087 | ||
Age at first medication | 25.4 | 7.3 | 22.8 | 5.2 | 1.187 | 31 | 0.244 | ||
Antipsychotic medication dose (mg/day in chlorpromazine equivalents) | 313.1 | 426.7 | 168.8 | 130.3 | 1.444 | 39 | 0.157 |
Range, 18–41 years for the patient groups and 18–35 years for the comparison group.
Edinburgh Inventory scores; ranges, 0.41–1.00 for the schizophrenia group, 0.44–1.00 for the affective psychosis group, and 0.47–1.00 for the comparison group.
Higher scores indicate lower socioeconomic status. Socioeconomic status was significantly lower for the schizophrenia group than for comparison subjects (Tukey’s honestly significant difference test, p=0.011).